The comparison of mFOLFOXIRI with CAOX/SOX as neoadjuvant chemotherapy for locally advanced rectal cancer.

Tetsuji Terazawa,Hiroyuki Kodama,Hiroki Yukami,Masahiko Aoki,Takahiro Miyamoto,Ken Asaishi,Toshifumi Yamaguchi,Takayuki Kii,Masahiro Goto,Keitaro Tanaka,Junji Okuda,Kazuhide Higuchi

The comparison of mFOLFOXIRI with CAOX/SOX as neoadjuvant chemotherapy for locally advanced rectal cancer.

2020

Tetsuji Terazawa
Hiroyuki Kodama
Hiroki Yukami
Masahiko Aoki
Takahiro Miyamoto
Ken Asaishi
Toshifumi Yamaguchi
Takayuki Kii
Masahiro Goto
Keitaro Tanaka
Junji Okuda
Kazuhide Higuchi

51Background: The standard therapy for the locally advanced rectal cancer (LARC) (Ra or Rb, T2Npsitive, T3/4Nany) is chemoradiotherapy (CRT) followed by surgery. The CRT prevents local recurrence, ...

Keywords:

Chemoradiotherapy
Internal medicine
Medicine
Colorectal cancer
Chemotherapy
Oncology
Pathology
standard therapy
locally advanced

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations